ResearcherCapital Medical UniversityNo recent work listed

Cuicui Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0077-727X; OpenAlex author ID A5053817652. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2022: 1 paper

Papers 1

Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models. Co-author DOI 10.1007/s00259-022-05954-y ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wenpeng Huang · 1 shared paper, 2022 · strength 0.14
- Paper Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models. DOI 10.1007/s00259-022-05954-y ↗
Xu Yang · 1 shared paper, 2022 · strength 0.14
- Paper Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models. DOI 10.1007/s00259-022-05954-y ↗
Lei Kang · 1 shared paper, 2022 · strength 0.14
- Paper Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models. DOI 10.1007/s00259-022-05954-y ↗
Jigang Yang · 1 shared paper, 2022 · strength 0.14
- Paper Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models. DOI 10.1007/s00259-022-05954-y ↗
Qingfang Miao · 1 shared paper, 2022 · strength 0.14
- Paper Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models. DOI 10.1007/s00259-022-05954-y ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.